|Articles|June 1, 2002

Bexarotene tabbed for localized CTCL

New Orleans - Bexarotene gel (Targretin) appears to be both effective and well tolerated for long-term use in early-stage cutaneous T-cell lymphoma, according to a poster presentation at the American Academy of Dermatology annual meeting.

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


Latest CME